SCHEMBL6161816

SCHEMBL6161816

CC(C)(C)OC(=O)CC(=O)SC1CCC(=O)N1Cc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 8/20 0.48
HCRTR2 O43614 8/20 0.48
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
GAA P10253 1/20 0.38
DRD2 P14416 1/20 0.38
LTA4H P09960 1/20 0.38
ITGB2 P05107 1/20 0.38
ICAM1 P05362 1/20 0.38
ITGAL P20701 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6157886 0.87 HCRTR2 (0.49) HCRTR1HCRTR2ALOX15TSHRKMT2A
SCHEMBL6158510 0.87 HCRTR1 (0.52) HCRTR1HCRTR2ALOX15TSHRKMT2A
SCHEMBL6157789 0.84 HCRTR2 (0.54) HCRTR1HCRTR2ALOX15TSHRKMT2A
SCHEMBL6160316 0.83 HCRTR2 (0.53) HCRTR1HCRTR2ALOX15TSHRKMT2A
SCHEMBL6160370 0.81 HCRTR1 (0.51) HCRTR1HCRTR2HDAC1HDAC6
SCHEMBL6162691 0.80 HCRTR2 (0.48) HCRTR1HCRTR2KMT2AGAALTA4H
SCHEMBL6162062 0.80 HCRTR1 (0.56) HCRTR1HCRTR2HDAC1HDAC6LTA4H
SCHEMBL6159396 0.79 HCRTR1 (0.56) HCRTR1HCRTR2KMT2AHDAC1HDAC6
SCHEMBL6161039 0.79 HCRTR1 (0.53) HCRTR1HCRTR2ALOX15TSHRKMT2A
SCHEMBL6158308 0.79 HCRTR1 (0.53) HCRTR1HCRTR2TSHRKMT2AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 HCRTR1 1930/4885HCRTR2 1754/4885ALOX15 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.